ID
Brain Abscess
search
Brain Abscess
, Intracranial Abscess, Cerebral Abscess, Central Nervous System Abscess, CNS Abscess
See Also
Subdural Abscess
Epidural Abscess
Intracranial Mass
Bacterial Meningitis
Bacterial Meningitis Management
Neisseria Meningitidis
Viral Meningitis
Aseptic Meningitis
Encephalitis
Brain Abscess
Viral Meningitis
Aseptic Meningitis
Encephalitis
Epidemiology
Peak
Incidence
in children: Ages 4 to 7 years old
Pathophysiology
Frontal, temporal, and
Parietal Lobe
s are most commonly affected
Causes
Source
Unknown primary source of abscess in 20-40% of cases
Direct Spread
Subdural Abscess
(
Subdural Empyema
) is spread of
Sinusitis
or
Mastoiditis
in 60-90% of cases
Mastoiditis
(due to
Chronic Otitis Media
)
Frontal Sinus
itis or
Ethmoid Sinus
itis
Most common in children who have highly vascular sinuses
Dental Infection
Retained Foreign Body
such as bullet fragments (abscess development may be years later)
Neurosurgery (abscess development may be >1 year later)
Epidural Abscess
(rare)
Skull
Osteomyelitis
Orbital Cellulitis
Acute Sinusitis
Otitis Media
Hematogenous spread
Lung Abscess
or empyema in host with chronic lung disease (e.g.
Cystic Fibrosis
,
Bronchiectasis
)
Esophageal procedures (e.g. esophageal dilation,
Varices
management)
Cyanotic Congenital Heart Disease
Bacterial Endocarditis
Pulmonary
AV Malformation
with right to left shunt
Skin Infection
s
Intraabdominal and pelvic infections
Dental Infection
Causes
Organisms
Strepotococcus esp. viridans (60-70%), as well as pneumococcus
Staphylococcus
, esp.
Staphylococcus aureus
(10-14%)
Other source site-specific organisms (in addition to
Staphylococcus
and
Streptococcus
species)
Actinomyces (lung)
Bacteroides
(sinus, dental, ear) in up to 20-40% of cases
Clostridium
(penetrating
Head Trauma
)
Enterobacter
iaciae,
Gram Negative Rod
s (ear) in up to 25-33% of cases
Enterobacter
(urine, penetrating
Head Trauma
, neurosurgery)
Fusobacterium
(sinus, dental, lung)
Haemophilus
Influenza
e (sinus, dental)
Pseudomonas
(ear, urine, neurosurgery)
Immunocompromised
patients
See
Brain Lesion in HIV
Aspergillus
Coccidioides
Cryptococcus
Listeria
Nocardia
Toxoplasma gondii
Other fungus (e.g. Candida)
Immigrant
s
Cysticercosis
(most common)
Entamoeba histolytica
Schistosoma
Symptoms
Often initially subacute (results in delayed diagnosis typically >1 week)
However,
Subdural Empyema
may rapidly progress
Headache
(69%), typically unilateral in the region of abscess
Neck Stiffness (15%), associated with posterior abscess (e.g. occiput)
Vomiting
(suggests
Increased Intracranial Pressure
)
Signs
Fever
(45%)
Focal neurologic deficit (50%)
Often a delayed finding (>1 week after
Headache
onset)
Oculomotor findings (
CN 3
or
CN 6
) suggests
Increased Intracranial Pressure
Seizure
(25%)
Altered Level of Consciousness
(associated with significant brain edema and with worse prognosis)
Imaging
CT Head
with contrast OR
MRI Brain
with gadolinium (preferred)
Differential Diagnosis
See
Intracranial Mass
Diagnostics
Lumbar Puncture
Contraindicated in focal symptoms/signs, CNS mass,
Increased Intracranial Pressure
(risk of
Hernia
tion)
Obtain CNS imaging prior to
Lumbar Puncture
Labs
Serology
Blood anti-Toxoplasma IgG
CSF anti-cysticercal
Antibody
CT-guided or neurosurgery obtained fluid
Gram Stain
Acid-fast stain and modified acid fast (
Mycobacteria
,
Nocardia
)
Fungal stains
Aeorbic and
Anaerobic Bacteria
l cultures
Mycobacteria
l culture
Fungal Culture
Management
See
Toxoplasmosis
Bacteria
l cause (initial empiric therapy, including for
Subdural Empyema
)
Overall
Antibiotic
course of 4-6 weeks is typical
Cefotaxime
2 g IV q4 hours OR
Ceftriaxone
2 g IV every 12 hours (or Pen G 3-4 MU q4h) AND
Metronidazole
7.5 mg/kg every 6 hours
Add
Vancomycin
for suspected
Staphylococcus aureus
Nocardia
initial empiric therapy
Trimethoprim-Sulfamethoxazole (or
Linezolid
500 mg IV or oral every 12 hours) AND
Imipenem
500 mg IV every 6 hours (or
Meropenem
2 g IV every 8 hours)
Add
Amikacin
7.5 mg/kg every 12 hours, if multiorgan involvement
Post-
Trauma
or Post-Surgical
Vancomycin
15-20 mg/kg every 8-12 hours (or Linzeolid 600 mg q12h) AND
Cefepime
2 g IV every 8 hours (or
Meropenem
2 g IV every 8 hours)
References
(2016) Sanford Guide, accessed 4/9/2016
Southwick in Calderwood (2016) UpToDate, accessed 4/9/2016
Brouwer (2014) N Engl J Med 371:447 [PubMed]
Type your search phrase here